Wharton's Jelly and exosome preparations sourced from Vitacell Bio Global.
Our regenerative biologics are sourced exclusively through Vitacell Bio Global, a regulated tissue bank with established quality standards and chain-of-custody documentation. These products are coordinated through licensed providers for supportive and investigational purposes.
All regenerative products are minimally manipulated human cellular tissue products (HCTPs) that comply with FDA 361 HCT/P regulations. They are not stem cell therapies and are not approved for the treatment of any specific disease.
Minimally manipulated tissue products sourced from regulated tissue banks, coordinated through licensed providers for supportive applications.
Signaling vesicle preparations that support cellular communication and tissue repair processes.
Certificates of Analysis — Every product shipment includes verified COA documentation.
Regulated Tissue Bank Sourcing — Products sourced exclusively from regulated tissue banks with established compliance records.
Compliant Terminology — All product descriptions, marketing materials, and patient communications use compliant language.
Injection Training Coordination — Clinical education and hands-on training for providers administering regenerative products.